BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
Biora Therapeutics Inc (BIOR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-125.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $127.97M | $-129.11M | 28.05% | -89.27% | -100.88% |
| 2019 | $143.99M | $-148.04M | 30.21% | -97.31% | -102.81% |
| 2020 | $74.31M | $-192.53M | -25.73% | -262.66% | -259.08% |
| 2021 | $1.25M | $-178.52M | 100.00% | -9,449.64% | -14,316.04% |
| 2022 | $305000.00 | $-38.16M | 100.00% | -20,256.07% | -12,510.49% |
| 2023 | $4000.00 | $-124.11M | 100.00% | -1,678,575.00% | -3,102,875.00% |